Sage Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 4.85 M | $26.34 M | -10.02% | 7.94% |
VANGUARD GROUP INC | 02/11/2025 | 4.84 M | $26.27 M | -16.01% | 7.92% |
MORGAN STANLEY | 02/14/2025 | 4.59 M | $24.95 M | 468.05% | 7.52% |
BELLEVUE GROUP AG | 02/14/2025 | 4.46 M | $24.22 M | 0.00% | 7.30% |
FMR LLC | 02/13/2025 | 4.12 M | $22.36 M | -21.89% | 6.74% |
CALIGAN PARTNERS LP | 02/14/2025 | 3.05 M | $16.58 M | 100.00% | 4.99% |
RTW INVESTMENTS, LP | 02/14/2025 | 3.00 M | $16.30 M | -46.31% | 4.91% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.62 M | $8.82 M | 8.32% | 2.66% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.59 M | $8.60 M | 67.44% | 2.59% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 1.39 M | $7.54 M | 100.00% | 2.27% |
STATE STREET CORP | 02/14/2025 | 1.27 M | $6.91 M | -56.51% | 2.08% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.26 M | $6.83 M | 1.13% | 2.06% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 1.12 M | $6.10 M | -10.85% | 1.84% |
FEDERATED HERMES, INC. | 02/13/2025 | 1.11 M | $6.00 M | 63.73% | 1.81% |
D. E. SHAW & CO., INC. | 02/14/2025 | 720,105 | $3.91 M | 11.29% | 1.18% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 630,000 | $3.42 M | 5.00% | 1.03% |
JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 599,042 | $3.25 M | -3.76% | 0.98% |
AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 560,429 | $3.04 M | 38.80% | 0.92% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 542,247 | $2.94 M | -29.61% | 0.89% |
NORTHERN TRUST CORP | 02/14/2025 | 524,420 | $2.85 M | 5.97% | 0.86% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 485,355 | $2.64 M | -0.81% | 0.79% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 462,309 | $2.51 M | 2.24% | 0.76% |
JANE STREET GROUP, LLC | 02/14/2025 | 462,004 | $2.51 M | 103.10% | 0.76% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 450,795 | $2.45 M | -12.18% | 0.74% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 414,221 | $2.25 M | -8.08% | 0.68% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 316,673 | $1.72 M | -52.87% | 0.52% |
HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 247,000 | $1.34 M | -28.41% | 0.40% |
PDT PARTNERS, LLC | 02/14/2025 | 235,097 | $1.28 M | 37.25% | 0.38% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 222,726 | $1.21 M | 100.00% | 0.36% |
PINNACLE ASSOCIATES LTD | 02/14/2025 | 220,198 | $1.20 M | 30.62% | 0.36% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 215,871 | $1.17 M | 100.00% | 0.35% |
JPMORGAN CHASE & CO | 02/12/2025 | 181,354 | $984,752 | 20.24% | 0.30% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 171,444 | $930,941 | -5.33% | 0.28% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 169,057 | $917,980 | 157.86% | 0.28% |
VERITION FUND MANAGEMENT LLC | 02/14/2025 | 169,015 | $917,751 | 23.89% | 0.28% |
UBS GROUP AG | 02/14/2025 | 162,890 | $884,493 | -2.72% | 0.27% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 152,726 | $829,303 | 100.00% | 0.25% |
HRT FINANCIAL LP | 02/14/2025 | 150,827 | $818,000 | -12.34% | 0.25% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 144,662 | $785,515 | -17.65% | 0.24% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 142,694 | $774,829 | 0.00% | 0.23% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 139,748 | $759,000 | 100.00% | 0.23% |
TORONTO DOMINION BANK | 02/19/2025 | 136,723 | $742,406 | 100.00% | 0.22% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 129,750 | $704,542 | -19.81% | 0.21% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 125,630 | $682,171 | -41.29% | 0.21% |
CITADEL ADVISORS LLC | 02/14/2025 | 121,500 | $659,745 | 2.88% | 0.20% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 120,723 | $655,526 | -35.11% | 0.20% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 117,799 | $639,649 | -2.16% | 0.19% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 108,200 | $587,526 | 0.00% | 0.18% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 106,792 | $579,881 | -67.89% | 0.17% |
BARCLAYS PLC | 02/13/2025 | 95,448 | $518,000 | -25.31% | 0.16% |
Sage Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 269 institutional investors and hedge funds held shares of Sage Therapeutics, Inc.. The most heavily invested institutionals were:
AdvisorNet Financial, Inc: 0
Assenagon Asset Management S.A.: 0
HARBOR CAPITAL ADVISORS, INC.: 0
Farther Finance Advisors, LLC: 0
BlackRock, Inc.: 4.85 M
VANGUARD GROUP INC: 4.84 M
83.81% of Sage Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 71.77 M shares in the last 24 months. This purchase volume represents approximately $527.54 M in transactions.